NCT03195088View on ClinicalTrials.gov

Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 27, 2017

Primary Completion Date

November 14, 2017

Study Completion Date

November 14, 2017

Conditions
Healthy
Interventions
DRUG

BI 473494

Solution for injection

DRUG

Placebo

Solution for injection

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY